|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash and due from banks | |||||||||||||||
| Interest bearing deposits | |||||||||||||||
| Total cash and cash equivalents | |||||||||||||||
| Time deposits | |||||||||||||||
| Federal funds sold | |||||||||||||||
| Securities available for sale | |||||||||||||||
| Non-marketable equity securities | |||||||||||||||
| Loans, net of allowance for loan losses of $3,357,596 and $2,937,632 at March 31, 2020 and December 31, 2019, respectively | |||||||||||||||
| Loans held for sale | |||||||||||||||
| Premises and equipment, net | |||||||||||||||
| Accrued interest receivable | |||||||||||||||
| Foreclosed real estate | |||||||||||||||
| Deferred tax assets | |||||||||||||||
| Cash surrender value of life insurance | |||||||||||||||
| Goodwill | |||||||||||||||
| Core deposit intangible | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities | |||||||||||||||
| Non-interest bearing | |||||||||||||||
| Interest bearing | |||||||||||||||
| Total deposits | |||||||||||||||
| Accrued interest payable | |||||||||||||||
| FHLB advances | |||||||||||||||
| Federal funds purchased | |||||||||||||||
| Other liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Redeemable common stock held by ESOP plan | |||||||||||||||
| Stockholders' Equity | |||||||||||||||
| Common stock, $0.01 par value, 12,000,000 shares authorized; 3,119,598 and 3,159,494 shares issued at March 31, 2020 and December 31, 2019, respectively | |||||||||||||||
| Additional paid-in-capital | |||||||||||||||
| Retained earnings | |||||||||||||||
| Unallocated Employee Stock Ownership Plan (ESOP) shares | |||||||||||||||
| Unallocated ESOP shares | |||||||||||||||
| Unearned management recognition plan shares | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| us-gaap_StockholdersEquityBeforeTreasuryStock | |||||||||||||||
| Maximum cash obligation related to ESOP shares | |||||||||||||||
| Total stockholders' equity | |||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||
Loading...
